Minimizing hazards associated with cancer vaccines

Dec 12, 2016

Sheri McMahon, Senior Research Nurse Specialist with the Genitourinary Malignancies Branch, published an article in the latest issue of the Clinical Journal of Oncology Nursing on minimizing hazards associatied with live-virus immunotherapeutic cancer vaccine injection sites. She says oncology nurses need to be familiar with how to manage patients' vaccine injection sites to minimize risks for patients and the community at large. Learn more...

 

Minimizing hazards associated with cancer vaccines

New York Times features patient in Rosenberg’s immunotherapy trial

Dec 9, 2016

Steven Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, led a study published in the New England Journal of Medicine that identified a method for targeting the cancer-causing protein produced by a mutant form of the KRAS gene. The study involved only one patient, Celine Ryan, whose advanced colon cancer was successfully treated. The New York Times featured her treatment and recovery. Read More…

New York Times features patient in Rosenberg’s immunotherapy trial

Edward Cowen discusses dermatology minerals on display at the NIH-Smithsonian exhibit

Dec 7, 2016

Edward Cowen, Senior Clinician in the Dermatology Branch, discussed the use of minerals in dermatology as part of the “Minerals in Medicine” exhibit in the NIH Clinical Research Center. The 18-month exhibit is put on by the Clinical Center and the Smithsonian National Museum of Natural History. Copper and sulfur are two of the minerals on display at the exhibit, and Cowen described how copper ions have been used for centuries as a disinfecting agent and sulfur is used in many different antibiotics and topical products. Read more...

Edward Cowen discusses dermatology minerals on display at the NIH-Smithsonian exhibit

Rosenberg featured as Cancer Research Pioneer

Dec 2, 2016

CCR's Steven Rosenberg is featured in the December "Changing Lives" issue of Bethesda Magazine as a cancer research pioneer, part of the cutting edge medicine happening at NIH.  Rosenberg's "relentless" focus on cell therapy approaches has been shown to shrink tumors in some cancers.  "We are on the verge of some really important advances", says Rosenberg.  Read more...

Rosenberg featured as Cancer Research Pioneer
Andrea Apollo, M.D.

Andrea Apolo discusses why patients are never forgotten

Nov 18, 2016

Andrea Apolo, Investigator in the Genitourinary Malignancies Branch and Head of the Bladder Cancer Section, reflects on her clinical trial patients in the Bladder Cancer Advocacy Network's fall newsletter . She says: "Every time I use data derived from a patient in one of our clinical trials, I think about them; I think about their family, their loved ones. I remember the conversations we had while they were in clinic about politics, travel and the hobbies they enjoyed. I have memories of hundreds of study patients, and I am very grateful to each of them for their altruistic contribution to my research."

Andrea Apolo discusses why patients are never forgotten

Clinical Research Center welcomes first-ever National Cancer Reporting Fellowship

Nov 18, 2016

The first-ever National Cancer Reporting Fellowship came to the NCI this fall for a 4-day workshop designed to improve how the media reports on cancer research and give fellows an opportunity to interact with the people they report on. During their tour of the Clinical Research Center, the fellows heard from CCR investigators James Gulley, M.D., Ph.D., Christian Hinrichs, M.D., and Peter Choyke, M.D., F.A.C.R.   Learn more...

 

 

Clinical Research Center welcomes first-ever National Cancer Reporting Fellowship

Lori Wiener discusses psychosocial impacts of childhood cancers

Nov 14, 2016

Lori Wiener, co-director of the Behavioral Health Core and head of the Psychosocial Support and Research Program, was quoted in HemOnc Today on the evolution of psychosocial care for cancer patients. She says that providing psychosocial care to patients can help improve their overall care. “We have to communicate information to pediatric patients in a way that is truthful and developmentally appropriate, and we need to be able to include them in medical decision-making in an age-appropriate way,” she says. “Providing family centered care is essential. The diagnosis of cancer in a child is a life-changing event for everyone in the family and attention to ongoing parental and family needs is required for optimal psychosocial care to be provided.”

Lori Wiener discusses psychosocial impacts of childhood cancers

MPNST state of the science: outlining a research agenda for the future

Oct 27, 2016

In October 2016, clinicians and scientists from around the world gathered on the NIH campus to exchange ideas on the future of malignant peripheral nerve sheath tumor (MPNST) research. Learn more...

Over 200 people attended the first Cancer Health Disparities Interest Group Research Symposium on October 18th

Oct 25, 2016

The causes of cancer health disparities are multi-faceted and the approaches needed to understand and overcome them are multi-disciplinary.  Learn more...

Christina Annunziata discusses PARP inhibitors with STAT

Oct 17, 2016

Christina Annunziata, Investigator in the Women’s Malignancies Branch, spoke with STAT about PARP inhibitors, a new class of drugs for ovarian cancer treatment. She has studied the efficacy of Lynparza, a PARP inhibitor, and says more clinical trials using PARP inhibitors with other cancer treatments will become more prevalent. Learn more...

Christina Annunziata discusses PARP inhibitors with STAT

Pages